Bharti Airtel Ltd., Lupin Ltd., Inox Wind Ltd., and Zydus Lifesciences Ltd. will be among the stocks that are likely to see action going into trade on Monday.

  • Bharti Airtel: The Supreme Court has dismissed Bharti Airtel arm Bharti Telemedia Ltd.’s appeal against high court judgements to levy entertainment tax on DTH services. The total estimated exposure pursuant to judgment is at Rs 585 crore.

  • TVS Srichakra: Eurogrip Tyres opened a branded retail store in Hyderabad. Eurogrip is the company’s two and three-wheeler tyre brand.

  • Lloyds Engineering Works: The company received an order worth Rs 21 crore from Cochin Shipyard to supply fin stabiliser systems.

  • Garware Hi-Tech: The company re-appointed Sarita Garware Ramsay as joint managing director for three years from May 26.

  • Lupin: US unit converts $41 million loan and outstanding interest of $3.3 million to Lupin Oncology into equity. Upon conversion of loan, Lupin Oncology becomes step-down subsidiary of the company.

  • Havells (India): The company is set to make an investment of Rs 340 crore to further hike cables capacity at its Alwar plant. The plant’s total annual capacity of cables will be 41.45 lakh Km.

  • Sun Pharma: The company will make an investment of $25 million in US-based Pharmazz.

  • Zydus Lifesciences: The company received US Food And Drugs Administration nod for Isotretinoin Capsules USP – 10 mg, 20 mg, 25 mg, 30 mg, 35 mg and 40 mg.

  • Bajaj Auto: The company’s arm is in call option agreement with Pierer Konzerngesellschaft mbH and Pierer Industrie AG for right to purchase from Pierer Industrie AG the shares held in Pierer Bajaj AG.

  • Inox Wind Energy: NCLT approved the scheme of arrangement between Inox Wind Energy, Inox Wind and shareholders.

Earnings Reactions To Watch

JSW Steel Q4 FY25 Results Highlights (Consolidated, QoQ)

  • Revenue up 8.3% to Rs 44,819.00 crore versus Rs 41,378.00 crore (Bloomberg estimate: Rs 44,720 crore)

  • Ebitda up 14.3% to Rs 6,378 crore versus Rs 5,579 crore (Bloomberg estimate: Rs 6,548 crore)

  • Margin at 14.2% versus 13.5% (Bloomberg estimate: 14.6%)

  • Net profit up 109.6% to Rs 1,503 crore versus Rs 717 crore (Bloomberg estimate: Rs 1,608 crore)

  • Exceptional items at Rs 44 crore vs Rs 103 crore.

  • India capacity utilisation of 93% in Q4, 91% in FY 25

  • Consolidated crude steel production of 7.63 MT in Q4 (up 12% YoY), 27.79 MT in FY25 (up 5% YoY)

  • Consolidated steel sales of 7.49 MT in Q4 (up 11% YoY), 26.45 MT in FY25 (up 7% YoY)

  • Domestic sales up 30% YoY, while Exports fell 58% YoY in Q4 Fiscal 2025

  • Domestic sales up 15% YoY, while Exports fell 39% YoY in Fiscal 2025

  • FY25 Guidance Achievement: Production 98% & Sales 98%

  • Guidance of Total Consolidated Volumes for Fiscal 2026: Production 30.5 MT & Sales 29.2 MT.

Dreamfolks Services Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 11.7% at Rs 314.1 crore versus Rs 281.1 crore

  • Ebitda down 19.1% at Rs 19.9 crore versus Rs 24.6 crore

  • Margin at 6.3% versus 8.8%

  • Net Profit down 17.2% at Rs 14.9 crore versus Rs 18 crore

Azad Engineering Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 36.9% at Rs 126.9 crore versus Rs 92.7 crore

  • Ebitda up 45.8% at Rs 45.5 crore versus Rs 31.2 crore

  • Margin at 35.9% versus 33.7%

  • Net Profit up 69% at Rs 25.2 crore versus Rs 14.9 crore

Balkrishna Industries Q4 FY25 Results Highlights (Standalone, YoY)

  • Revenue up 2.8% to Rs 2,746.6 crore versus Rs 2,673 crore (Bloomberg estimate: Rs 2716.5 crore)

  • Ebitda down 9.6% to Rs 602 crore versus Rs 665 crore (Bloomberg estimate: Rs 691 crore)

  • Margin at 21.9% versus 24.9% (Bloomberg estimate: 25.4%)

  • Net profit down 24.7% to Rs 362 crore versus Rs 481 crore (Bloomberg estimate: Rs 448.5 crore)

Glenmark Pharma Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 6.3% at Rs 3,256 crore versus Rs 3,063 crore (Bloomberg estimate: Rs 3,365 crore)

  • Ebitda up 11% at Rs 561 crore versus Rs 504 crore (Bloomberg estimate: Rs 598 crore)

  • Margin at 17.2% versus 16.5% (Bloomberg estimate: 17.8%)

  • Net Profit at Rs 4.7 crore versus a loss of Rs 1,218 crore (Bloomberg estimate: Rs 344 crore)

  • Exceptional Item of Rs 373 crore vs 447 crore

  • Loss in Q4FY24 due to higher tax expense of Rs 1,769 crore.

Reliance Infrastructure Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue down 12.3% at Rs 4,108 crore versus Rs 4,686 crore

  • Ebitda down 95.5% at Rs 14.3 crore versus Rs 317.3 crore

  • Margin at 0.3% versus 6.8%

  • Net Profit at Rs 4,387 crore versus a loss of Rs 220.6 crore

  • Note: Regulatory Income (net of deferred tax) of Rs 8,274 crore. Exceptional item of Rs 514 crore in Q4FY25 compared to Rs 220 crore in Q4FY24.

Anupam Rasayan Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 24.7% at Rs 500 crore versus Rs 401 crore

  • Ebitda up 55.8% at Rs 144.3 crore versus Rs 92.6 crore

  • Margin at 28.9% versus 23.1%

  • Net Profit up 44% at Rs 44.5 crore versus Rs 30.9 crore

  • Performance supported by growth in pharma and polymer coupled with strong performance from Tanfac.

  • Q4 saw meaningful improvement with sales increasing both year-on-year and sequentially.

Linde India Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue down 6.1% at Rs 591.8 crore versus Rs 630 crore

  • Ebitda up 17.6% at Rs 209.8 crore versus Rs 178.4 crore

  • Margin at 35.5% versus 28.3%

  • Net Profit up 12.3% at Rs 118.4 crore versus Rs 105.4 crore

Anupam Rasayan Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 24.7% at Rs 500 crore versus Rs 401 crore

  • Ebitda up 55.8% at Rs 144.3 crore versus Rs 92.6 crore

  • Margin at 28.9% versus 23.1%

  • Net Profit up 44% at Rs 44.5 crore versus Rs 30.9 crore

GE Vernova Q4 FY25 Results Highlights (YoY)

  • Revenue up 26% at Rs 1,153 crore versus Rs 913.6 crore

  • Ebitda at Rs 252 crore versus Rs 110.9 crore

  • Margin at 21.9% versus 12.1%

  • Net Profit at Rs 186.4 crore versus Rs 66.2 crore

Lux Industries Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 15.6% at Rs 817.7 crore versus Rs 707.6 crore

  • Ebitda up 1.4% at Rs 76.6 crore versus Rs 75.6 crore

  • Margin at 9.4% versus 10.7%

  • Net Profit down 13.4% at Rs 48.1 crore versus Rs 55.5 crore

Cello World Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 14.9% to Rs 588.8 crore versus Rs 512.5 crore

  • Ebitda up 1.4% to Rs 135.2 crore versus Rs 133.3 crore

  • Margin at 23% versus 26%

  • Net profit down 0.7% to Rs 88.2 crore versus Rs 88.8 crore

Gujarat Narmada Valley Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue down 2.6% at Rs 2,055 crore versus Rs 2,110 crore

  • EBITDA up 65.5% at Rs 240 crore versus Rs 145 crore

  • Margin at 11.7% versus 6.9%

  • Net Profit up 62.3% at Rs 211 crore versus Rs 130 crore

Afcons Infra Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue down 11.4% At Rs 3,223 crore versus Rs 3,636 crore (Cons, YoY)

  • Ebitda 17.3% At `294 crore versus Rs 355 crore (Cons, YoY)

  • Margin At 9.1% Vs 9.8% (Cons, YoY) 

  • Net Profit down 23.4% At Rs 111 crore  versus Rs 145 crore (Cons, YoY)

Timken India Q4 FY25 Results Highlights (Consolidated, YoY)

  • Net Profit up 32% At Rs 186.8 crore versus Rs 141.4 crore

  • Revenue up 4.7% At Rs 939.8 crore versus Rs 897.8 crore

  • Ebitda up 5.6% At Rs 209.7 crore versus Rs 198.7 crore

  • Margin at 22.3% versus 22.1%

Aditya Birla Fashion Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 9.2% At Rs 1,719.5 crore versus Rs 1,575 crore

  • Ebitda at Rs 205 crore versus Rs 35 crore

  • Margin at 12% versus 2.2%

  • Net loss at Rs 161 crore versus loss of Rs 287 crore

Narayana Hrudayalaya Q4 FY25 Results Highlights (Consolidated, YoY)

  • Revenue up 18.4% At Rs 1,475 crore versus Rs 1,246 crore

  • Ebitda up 22.9% At Rs 357.7 crore versus Rs 291 crore

  • Margin at 24.2% Vs 23.4%

  • Net profit up 3.4% At Rs 197.2 crore  Vs Rs 190.7 crore

Earnings To Watch

Action Construction Equipment, Akums Drugs and Pharmaceuticals, Aurobindo Pharma, Awfis Space Solutions, Balaji Amines, Bayer CropScience, Blue Dart Express, Capacite Infraprojects, Brainbees Solutions, General Insurance Corporation of India, Gillette India, Goldiam International, Hi-Tech Pipes, Infibeam Avenues, KEC International, Lumax Industries, Maharashtra Seamless, Nazara Technologies, Olectra Greentech, Orchid Pharma, Apeejay Surrendra Park Hotels, PTC India, RateGain Travel Technologies, Schneider Electric Infrastructure, Shilpa Medicare, Stylam Industries, Sumitomo Chemical India, Vadilal Industries, Venus Pipes & Tubes, Yatharth Hospital & Trauma Care Services.

. Read more on Markets by NDTV Profit.Bajaj Auto and Sun Pharmaceuticals will be some of the other stocks to watch before going into trade on Monday.  Read MoreMarkets, Business, Notifications 

​NDTV Profit